About Fauna Bio
Fauna Bio is a company based in Berkeley (United States) founded in 2018 by Ashley Zehnder, Linda Goodman, and Katie Grabek. Fauna Bio has raised $13.1 million across 7 funding rounds from investors including NIH, HHS and Lifeforce Capital. Fauna Bio offers products and services including Convergence Platform. Fauna Bio operates in a competitive market with competitors including BeaconCure, Predxbio, Humaneva Group, Private Health Management and RegenMed, among others.
- Headquarter Berkeley, United States
- Founders Ashley Zehnder, Linda Goodman, Katie Grabek
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Fauna Bio Incorporated
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$13.1 M (USD)
in 7 rounds
-
Latest Funding Round
Not available
-
Investors
NIH
& 11 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Fauna Bio
Fauna Bio offers a comprehensive portfolio of products and services, including Convergence Platform.
AI tool for analyzing animal genetics to identify drug targets
People of Fauna Bio
Unlock access to complete
Funding Insights of Fauna Bio
Fauna Bio has successfully raised a total of $13.1M across 7 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Fauna Bio
Fauna Bio has secured backing from 12 investors, including institutional and venture fund investors. Prominent investors backing the company include NIH, HHS and Lifeforce Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on healthcare startups
|
Locked | Locked | Locked | |
|
Venture capital firm supporting AI founders through investments and community.
|
Locked | Locked | Locked | |
|
Early investments in science-focused startups are made by BOOM Capital.
|
Locked | Locked | Locked |
Investor details for Fauna Bio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Fauna Bio
Investment portfolio details for Fauna Bio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Fauna Bio
Detailed financials for Fauna Bio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Fauna Bio Comparisons
Peer comparison for Fauna Bio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Fauna Bio
Fauna Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BeaconCure, Predxbio, Humaneva Group, Private Health Management and RegenMed, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Data analytics and validation software for regulatory submission in the healthcare sector
|
|
| Locked | Locked | Locked |
AI-based drug discovery and clinical services are provided for biopharma.
|
|
| Locked | Locked | Locked |
Provider of clinical research data services for oncology & other therapeutic areas
|
|
| Locked | Locked | Locked |
Provides personalized healthcare guidance for complex diseases and partnerships.
|
|
| Locked | Locked | Locked |
Healthcare data analytics company that enables clinical and financial value creation for clinicians
|
Detailed competitors of Fauna Bio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Fauna Bio
Complete news archive for Fauna Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Fauna Bio
Fauna Bio was founded in 2018 and raised its 1st funding round 1 year after it was founded.
Fauna Bio is headquartered in Berkeley, United States. It is registered at Berkeley, California, United States.
Ashley Zehnder is the current CEO of Fauna Bio. They have also founded this company.
Fauna Bio is a funded company, having raised a total of $13.1M across 7 funding rounds to date.
Fauna Bio was founded in 2018 and is based in Berkeley, United States. Operations focus on the healthcare sector, with emphasis on animal genomics research. Services involve genomic analysis and applications derived from animal models to address human health challenges. The company is led by co-founders including Ashley Zehnder as CEO, Linda Goodman as CTO, and Katie Grabek as CSO, supporting advancements in biotechnology.
Fauna Bio's top competitors include Predxbio, BeaconCure and RegenMed.
Fauna Bio offers Convergence Platform.
Fauna Bio has 12 investors. Key investors include NIH, HHS, Lifeforce Capital, True Ventures, and BOOM Capital.